Page last updated: 2024-08-23

pravastatin and Scleroderma, Systemic

pravastatin has been researched along with Scleroderma, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amengual, O; Atsumi, T; Furukawa, S; Horita, T; Koike, T; Yasuda, S	1

Trials

1 trial(s) available for pravastatin and Scleroderma, Systemic

Article	Year
Protective effect of pravastatin on vascular endothelium in patients with systemic sclerosis: a pilot study. Annals of the rheumatic diseases, 2006, Volume: 65, Issue:8 Topics: Adult; Aged; Antithrombin III; Biomarkers; Case-Control Studies; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Peptide Hydrolases; Pilot Projects; Pravastatin; Scleroderma, Systemic; von Willebrand Factor	2006

Article

Year

Protective effect of pravastatin on vascular endothelium in patients with systemic sclerosis: a pilot study.

Annals of the rheumatic diseases, 2006, Volume: 65, Issue:8

Topics: Adult; Aged; Antithrombin III; Biomarkers; Case-Control Studies; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Peptide Hydrolases; Pilot Projects; Pravastatin; Scleroderma, Systemic; von Willebrand Factor

2006